Search Results - "Ndife, Briana"

Refine Results
  1. 1

    Targeted agents or immuno-oncology therapies as first-line therapy for BRAF-mutated metastatic melanoma: a real-world study by Luke, Jason J, Ghate, Sameer R, Kish, Jonathan, Lee, Choo Hyung, McAllister, Lindsay, Mehta, Sonam, Ndife, Briana, Feinberg, Bruce A

    Published in Future oncology (London, England) (01-09-2019)
    “…Targeted therapy (TT) and immuno-oncology (IO) drugs are approved for patients with BRAF mutant metastatic melanoma (MM). We compared real-world outcomes for…”
    Get full text
    Journal Article
  2. 2

    Cost Effectiveness of Midostaurin in the Treatment of Newly Diagnosed FLT3-Mutated Acute Myeloid Leukemia in the United States by Stein, Eytan, Xie, Jipan, Duchesneau, Emilie, Bhattacharyya, Subrata, Vudumula, Umakanth, Ndife, Briana, Bonifacio, Gaetano, Guerin, Annie, Li, Nanxin, Joseph, George

    Published in PharmacoEconomics (01-02-2019)
    “…Objectives The aim of this study was to assess the cost effectiveness of midostaurin + cytarabine + daunorubicin (midostaurin arm) versus placebo + cytarabine…”
    Get full text
    Journal Article
  3. 3

    Development and testing of an alternative responder definition for EULAR Sjögren’s Syndrome Patient Reported Index (ESSPRI) by Wratten, Samantha, Abetz-Webb, Linda, Arenson, Ethan, Griffiths, Pip, Bowman, Simon, Hueber, Wolfgang, Ndife, Briana, Kuessner, Daniel, Goswami, Pushpendra

    Published in Rheumatic & musculoskeletal diseases open (01-03-2023)
    “…ObjectivesDryness, fatigue and joint/muscle pain are typically assessed in Sjögren’s trials using European Alliance of Associations for Rheumatology Sjögren’s…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Atypical Hemolytic Uremic Syndrome (aHUS) Clinical Characteristics and Treatment Patterns Associated with Readmission after Index Hospitalization by Olson, Steve, Ndife, Briana, Nguyen, Jennifer, Nagelhout, Elizabeth, Ndiba-Markey, Colette, Shrestha, Swastina, Gor, Deval

    Published in Blood (02-11-2023)
    “…Introduction Atypical hemolytic uremic syndrome (aHUS) is associated with dysregulation of the alternative complement pathway and causes significant morbidity…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17

    Patient preferences for treatment of metastatic melanoma by Mansfield, Carol, Ndife, Briana, Chen, Joyce, Gallaher, Kathleen, Ghate, Sameer

    Published in Future oncology (London, England) (01-04-2019)
    “…To investigate patient preferences for clinical attributes of first-line metastatic melanoma treatments. A discrete-choice experiment and best-worst scaling…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20